# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000950170-24-060971
Filing Date
2024-05-16
Accepted
2024-05-16 14:16:50
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | rkda-fy23-defa14a.htm | DEFA14A | 16863
2 | GRAPHIC | img249949600_0.jpg | GRAPHIC | 492095
3 | GRAPHIC | img249949600_1.jpg | GRAPHIC | 530324
| Complete submission text file | 0000950170-24-060971.txt |  | 1425573

Mailing Address 202 COUSTEAU PLACE SUITE 105 DAVIS CA 95618
Business Address 202 COUSTEAU PLACE SUITE 105 DAVIS X1 95618 530-756-7077
Arcadia Biosciences, Inc. (Filer) CIK: 0001469443 (see all company filings)

EIN.: 810571538 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37383 | Film No.: 24954692
SIC: 0100 Agricultural Production-Crops
(CF Office: 08 Industrial Applications and Services)